تخطَّ إلى المحتوى
دليل الأدوية المصري
تابع آخر تحديثات الأسعار على واتساب

سعر ريفام 100مجم/5مل 60مل شراب معلق 2022

Rifam 100mg/5ml 60ml susp

معلومات الدواء

التفاصيل الكاملة
دواعي الاستعمالUses
  • Treatment of all forms of tuberculosis, as part of a multidrug regimen (e.g. with isoniazid and pyrazinamide in the initial phase).DailyMed (U.S. National Library of Medicine)
  • Asymptomatic carriers of Neisseria meningitidis, to eliminate meningococci from the nasopharynx (not for treatment of meningococcal infection).DailyMed (U.S. National Library of Medicine)
  • Treatment of all forms of tuberculosis, as part of a multidrug regimen (e.g. with isoniazid and pyrazinamide in the initial phase).DailyMed (U.S. National Library of Medicine)
  • Asymptomatic carriers of Neisseria meningitidis, to eliminate meningococci from the nasopharynx (not for treatment of meningococcal infection).DailyMed (U.S. National Library of Medicine)
الآثار الجانبيةSide effects
  • Gastrointestinal effects (heartburn, epigastric distress, anorexia, nausea, vomiting, flatulence, cramps, diarrhoea); pseudomembranous colitis reported.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Hepatic (transient LFT abnormalities, hepatitis), haematologic (thrombocytopenia, leukopenia, haemolytic anaemia), CNS (headache, drowsiness, dizziness, fatigue), flushing/itching and hypersensitivity reactions.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Gastrointestinal effects (heartburn, epigastric distress, anorexia, nausea, vomiting, flatulence, cramps, diarrhoea); pseudomembranous colitis reported.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • Hepatic (transient LFT abnormalities, hepatitis), haematologic (thrombocytopenia, leukopenia, haemolytic anaemia), CNS (headache, drowsiness, dizziness, fatigue), flushing/itching and hypersensitivity reactions.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
موانع الاستعمالContraindications
  • Hypersensitivity to rifampin, any component, or any rifamycin.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Concomitant ritonavir-boosted saquinavir (severe hepatocellular toxicity).معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Concomitant atazanavir, darunavir, fosamprenavir, saquinavir, tipranavir, cabotegravir, fostemsavir or lenacapavir (loss of antiviral efficacy).معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
عرض الكل (5)
  • Hypersensitivity to rifampin, any component, or any rifamycin.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • Concomitant ritonavir-boosted saquinavir (severe hepatocellular toxicity).General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • Concomitant atazanavir, darunavir, fosamprenavir, saquinavir, tipranavir, cabotegravir, fostemsavir or lenacapavir (loss of antiviral efficacy).General active-ingredient information · DailyMed (U.S. National Library of Medicine)
Show all (5)
تحذيرات واحتياطاتWarnings & precautions
  • Hepatotoxicity (hepatocellular, cholestatic or mixed), ranging up to fulminant liver failure and death; in hepatic impairment use only when necessary with liver monitoring every 2-4 weeks.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Systemic hypersensitivity reactions and severe cutaneous adverse reactions (SJS, TEN, AGEP, DRESS); discontinue if they occur.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Vitamin K-dependent coagulation disorders and bleeding; avoid high-dose cefazolin co-use in patients at bleeding risk.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
عرض الكل (4)
  • Hepatotoxicity (hepatocellular, cholestatic or mixed), ranging up to fulminant liver failure and death; in hepatic impairment use only when necessary with liver monitoring every 2-4 weeks.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • Systemic hypersensitivity reactions and severe cutaneous adverse reactions (SJS, TEN, AGEP, DRESS); discontinue if they occur.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • Vitamin K-dependent coagulation disorders and bleeding; avoid high-dose cefazolin co-use in patients at bleeding risk.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
Show all (4)
التداخلات الدوائيةDrug interactions
  • Drugs metabolised by CYP1A2, 2B6, 2C8, 2C9, 2C19, 3A4, UGT or transported by P-gp/MRP2Rifampin induces these enzymes/transporters and may decrease concentrations and effect of many co-administered drugs; adjust doses per their labeling.DailyMed (U.S. National Library of Medicine)
  • Isoniazid / halothane / other hepatotoxic drugsIncreased potential for hepatotoxicity; avoid halothane and monitor closely with isoniazid.DailyMed (U.S. National Library of Medicine)
  • Drugs metabolised by CYP1A2, 2B6, 2C8, 2C9, 2C19, 3A4, UGT or transported by P-gp/MRP2Rifampin induces these enzymes/transporters and may decrease concentrations and effect of many co-administered drugs; adjust doses per their labeling.DailyMed (U.S. National Library of Medicine)
  • Isoniazid / halothane / other hepatotoxic drugsIncreased potential for hepatotoxicity; avoid halothane and monitor closely with isoniazid.DailyMed (U.S. National Library of Medicine)
الحمل والرضاعةPregnancy & breastfeeding
  • No adequate well-controlled studies in pregnant women; rifampin crosses the placenta; decades of data have not established an association with major birth defects; use only if benefit outweighs risk.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • Because of tumorigenicity potential in animal studies, decide whether to discontinue nursing or the drug.معلومة عامة عن المادة الفعالة · DailyMed (U.S. National Library of Medicine)
  • No adequate well-controlled studies in pregnant women; rifampin crosses the placenta; decades of data have not established an association with major birth defects; use only if benefit outweighs risk.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
  • Because of tumorigenicity potential in animal studies, decide whether to discontinue nursing or the drug.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
كيف يعمل الدواءHow it works
  • Inhibits bacterial DNA-dependent RNA polymerase (rifamycin antibiotic).
  • Rifampicin: Inhibits bacterial DNA-dependent RNA polymerase (rifamycin antibiotic).

المثائل (2)

كل المثائل والبدائل

نفس المادة الفعالة والتركيز. اسأل الصيدلي قبل الاستبدال.

مثائل ريفام 100مجم/5مل 60مل شراب معلق بنفس المادة الفعالة والتركيز، مرتبة من الأرخص
ريفاموكس 100مجم/مل 30جم شراب معلقRifamox 100mg/5ml 30gm suspEl Nasr · 100 mg/5 mlالأرخصالسعر4.5ج.مالفرق عن الأصليأرخص 2.5ج.م (35.7%)
ريفاكتين 2% 60 مل معلقRifactine 2% 60ml suspMUP · 2%السعر37ج.مالفرق عن الأصليأغلى 30ج.م (428.6%)

المعرّفات

الباركود
6223000013106

أدوية ذات صلة

نفس المادة الفعالة بتركيز آخر

منتجات أخرى من Pharco

من فئة مضاد حيوي

المصادر

تعليقات

لا توجد تعليقات بعد. كن أول من يشارك تجربته مع هذا الدواء.

أضف تعليقًا

0/60

لا يُنشر أبدًا؛ للتواصل فقط إن لزم.

0/1000

من 20 إلى 1000 حرف. بدون روابط.

التعليقات للمعلومات العامة ولا تُعد نصيحة طبية. لا تذكر بيانات شخصية.